VRHI (Veri Medtech Holdings) Buyback Yield %: 0.00 (As of Jul. 09, 2026)


VRHI Veri Medtech Holdings Inc VRHI
35 GF Score
Price $1.95
View Full Analysis

What is Veri Medtech Holdings Buyback Yield %?

Veri Medtech Holdings VRHI 35 Buyback Yield % is 0.00 as of Jul. 09, 2026. GuruFocus rates VRHI with a GF Score™ of 35/100.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Veri Medtech Holdings's current buyback yield was 0.00%.

Veri Medtech Holdings Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Veri Medtech Holdings's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings Buyback Yield % Chart

Veri Medtech Holdings Annual Data
Trend Dec21
Buyback Yield %
0.00

Veri Medtech Holdings Semi-Annual Data
Dec21
Buyback Yield % 0.00

VRHI vs MMVVF, BLMZ, MVNC: Buyback Yield % Comparison

For the Health Information Services subindustry, Veri Medtech Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veri Medtech Holdings Buyback Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veri Medtech Holdings's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Veri Medtech Holdings's Buyback Yield % falls into.


VRHI
35GF Score
Veri Medtech Holdings Inc VRHI
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veri Medtech Holdings Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Veri Medtech Holdings's Buyback Yield for the fiscal year that ended in Dec. 2021 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) /
=N/A%

Veri Medtech Holdings's annualized Buyback Yield for the quarter that ended in Dec. 2021 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Veri Medtech Holdings (VRHI) has a Buyback Yield % of 0.00 as of Jul. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' Buyback Yield % too high?
Veri Medtech Holdings' current Buyback Yield % is 0.00. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' Buyback Yield % compare to MMVVF and BLMZ?
Veri Medtech Holdings' Buyback Yield % of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Veri Medtech Holdings and its competitors. Veri Medtech Holdings's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHI) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Veri Medtech Holdings (VRHI), the current Buyback Yield % is 0.00 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veri Medtech Holdings Business Description

Address 1660 International Drive, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score

Get the complete analysis for VRHI

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price